Ernexa Therapeutics Inc Share Price Today: Live Updates & Key Insights
Ernexa Therapeutics Inc share price today is $3.85, up -1.5%. The stock opened at $4.07 against the previous close of $3.99, with an intraday high of $4.12 and low of $3.95.
Ernexa Therapeutics Inc Share Price Chart
Ernexa Therapeutics Inc
Ernexa Therapeutics Inc Share Price Performance
Ernexa Therapeutics Inc Institutional Holdings
Ernexa Therapeutics Inc Market Status
Ernexa Therapeutics Inc Fundamentals
Market Cap 4.65 M
PB Ratio 0.7568
PE Ratio 0.0
Enterprise Value -3.60 M
Total Assets 5.83 M
Volume 32967
Ernexa Therapeutics Inc Company Financials
About Ernexa Therapeutics Inc & investment objective
Company Information Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 5
Industry Biotechnology
CEO Mr. Sanjeev Luther
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Ernexa Therapeutics Inc FAQs
What is the share price of Ernexa Therapeutics Inc today?
The current share price of Ernexa Therapeutics Inc is $3.85.
Can I buy Ernexa Therapeutics Inc shares in India?
Yes, Indian investors can buy Ernexa Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Ernexa Therapeutics Inc shares in India?
You can easily invest in Ernexa Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Ernexa Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Ernexa Therapeutics Inc.
Can I buy fractional shares of Ernexa Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Ernexa Therapeutics Inc?
Ernexa Therapeutics Inc has a market cap of $4.65 M.
In which sector does Ernexa Therapeutics Inc belong?
Ernexa Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Ernexa Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Ernexa Therapeutics Inc?
The PE ratio of Ernexa Therapeutics Inc is N/A and the PB ratio is 0.76.